442 related articles for article (PubMed ID: 15337418)
1. Pathology of high-risk breast lesions and ductal carcinoma in situ.
Sewell CW
Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
[TBL] [Abstract][Full Text] [Related]
2. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
3. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
4. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
5. [Atypical ductal and lobular hyperplasia of the breast].
Bricou A; Delpech Y; Barranger E
Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
[TBL] [Abstract][Full Text] [Related]
6. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
Dauplat MM; Penault-Llorca F
Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
Gao F; Carter G; Tseng G; Chivukula M
Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
9. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
[TBL] [Abstract][Full Text] [Related]
10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
11. Proliferative lesions of the breast: carcinoma in situ.
Chinoy RF
Indian J Pathol Microbiol; 2003 Apr; 46(2):153-64. PubMed ID: 15022899
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
13. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
Wellings SR; Jensen HM; Marcum RG
J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
[TBL] [Abstract][Full Text] [Related]
14. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
[No Abstract] [Full Text] [Related]
15. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
Wagner PL; Kitabayashi N; Chen YT; Shin SJ
Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
[TBL] [Abstract][Full Text] [Related]
16. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
[No Abstract] [Full Text] [Related]
17. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?
Ellis IO; Pinder SE; Lee AH; Elston CW
Semin Diagn Pathol; 1999 Aug; 16(3):202-8. PubMed ID: 10490197
[TBL] [Abstract][Full Text] [Related]
18. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
19. Do breast columnar cell lesions with atypia need to be excised?
Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
[TBL] [Abstract][Full Text] [Related]
20. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]